Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,036 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Final analysis of a phase II study of nivolumab in combination with ipilimumab for unresectable chemotherapy-naive advanced melanoma.
Namikawa K, Kiyohara Y, Takenouchi T, Uhara H, Uchi H, Yoshikawa S, Takatsuka S, Koga H, Wada N, Minami H, Hatsumichi M, Namba Y, Yamazaki N. Namikawa K, et al. Among authors: yoshikawa s. J Dermatol. 2020 Nov;47(11):1257-1266. doi: 10.1111/1346-8138.15514. Epub 2020 Aug 18. J Dermatol. 2020. PMID: 32812243 Free PMC article. Clinical Trial.
Identification of melanoma antigens using a Serological Proteome Approach (SERPA).
Suzuki A, Iizuka A, Komiyama M, Takikawa M, Kume A, Tai S, Ohshita C, Kurusu A, Nakamura Y, Yamamoto A, Yamazaki N, Yoshikawa S, Kiyohara Y, Akiyama Y. Suzuki A, et al. Among authors: yoshikawa s. Cancer Genomics Proteomics. 2010 Jan-Feb;7(1):17-23. Cancer Genomics Proteomics. 2010. PMID: 20181627
Identification of cytomegalovirus (CMV)pp65 antigen-specific human monoclonal antibodies using single B cell-based antibody gene cloning from melanoma patients.
Iizuka A, Komiyama M, Tai S, Oshita C, Kurusu A, Kume A, Ozawa K, Nakamura Y, Ashizawa T, Yamamoto A, Yamazaki N, Yoshikawa S, Kiyohara Y, Yamaguchi K, Akiyama Y. Iizuka A, et al. Among authors: yoshikawa s. Immunol Lett. 2011 Mar 30;135(1-2):64-73. doi: 10.1016/j.imlet.2010.09.013. Epub 2010 Oct 12. Immunol Lett. 2011. PMID: 20932861
Applicability of radiocolloids, blue dyes and fluorescent indocyanine green to sentinel node biopsy in melanoma.
Uhara H, Yamazaki N, Takata M, Inoue Y, Sakakibara A, Nakamura Y, Suehiro K, Yamamoto A, Kamo R, Mochida K, Takenaka H, Yamashita T, Takenouchi T, Yoshikawa S, Takahashi A, Uehara J, Kawai M, Iwata H, Kadono T, Kai Y, Watanabe S, Murata S, Ikeda T, Fukamizu H, Tanaka T, Hatta N, Saida T. Uhara H, et al. Among authors: yoshikawa s. J Dermatol. 2012 Apr;39(4):336-8. doi: 10.1111/j.1346-8138.2011.01340.x. Epub 2011 Sep 20. J Dermatol. 2012. PMID: 21933261 Clinical Trial.
Dendritic cell-based vaccination in metastatic melanoma patients: phase II clinical trial.
Oshita C, Takikawa M, Kume A, Miyata H, Ashizawa T, Iizuka A, Kiyohara Y, Yoshikawa S, Tanosaki R, Yamazaki N, Yamamoto A, Takesako K, Yamaguchi K, Akiyama Y. Oshita C, et al. Among authors: yoshikawa s. Oncol Rep. 2012 Oct;28(4):1131-8. doi: 10.3892/or.2012.1956. Epub 2012 Aug 7. Oncol Rep. 2012. PMID: 22895835 Free PMC article. Clinical Trial.
Treatment strategy for cutaneous apocrine carcinoma.
Ogata D, Kiyohara Y, Yoshikawa S, Kasami M. Ogata D, et al. Among authors: yoshikawa s. Int J Clin Oncol. 2014 Aug;19(4):712-5. doi: 10.1007/s10147-013-0594-x. Epub 2013 Jul 31. Int J Clin Oncol. 2014. PMID: 23900624
1,036 results